Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00174746 | Dose Response Study of Inhaled Ciclesonide (Glucocorticosteroid) to Patients With Persistent Asthma | PHASE2 | COMPLETED | 1,145 | — | — | Mar 1, 2005 | Nov 1, 2005 | Apr 8, 2009 | 1 | United States |
| Name | Type | Description |
|---|---|---|
| AVE2635A | DRUG | - |
Inclusion Criteria: * Males or females 12 years or older; History of persistent bronchial asthma for at least 6 months; Documented use of an inhaled steroid for at least 1 month before screening; At screening, FEV1 40% or more of predicted normal and at randomization, FEV1 between 40 and 80% predic...